This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
We are very excited to launch our new website! Please take a few moments to click around and explore...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...